ImpediMed Limited (ASX:IPD)

Australia · Delayed Price · Currency is AUD

0.0180

-0.0010 (-5.26%)

Feb 26, 2026, 4:10 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Medical	12.72M	10.32M	11.34M	10.57M	8.41M
Medical Growth	23.31%	-9.04%	7.36%	25.65%	46.47%
Total	12.72M	10.32M	11.34M	10.57M	8.41M
Total Growth	23.31%	-9.04%	7.36%	25.65%	46.47%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
North America	11.48M	9.28M	8.26M	6.10M	5.25M
North America Growth	23.70%	12.39%	35.29%	16.33%	6.91%
Australia/Rest of World (ROW)	1.16M	892.00K	1.05M	1.13M	1.30M
Australia/Rest of World (ROW) Growth	29.48%	-14.80%	-6.93%	-13.66%	56.42%
Unallocated	88.00K	146.00K	2.04M	3.34M	1.86M
Unallocated Growth	-39.73%	-92.84%	-38.90%	79.51%	-
Total	12.72M	10.32M	11.34M	10.57M	8.41M
Total Growth	23.31%	-9.04%	7.36%	25.65%	46.47%

Source: S&P Global Market Intelligence.